DIAGAST
Gabriel Martin, PhD, is an experienced professional in the field of biology and immunology, currently serving as an Ingénieur projets at DIAGAST since December 2022. Previously, Gabriel held multiple roles at C4Diagnostics, including BU Scientific manager and molecular biology technician, where significant contributions included establishing a P2 laboratory for SARS-CoV-2 detection in environmental samples and leading the Eurêka project on antimicrobial activity on fabrics. Prior experience also includes responsibilities as Responsable de rayon en pharmacie, overseeing order management and client advisory for rheumatic diseases at Pharmacie de l'hippodrome. Gabriel's academic background features a PhD in Biology with a specialization in Immunology from Aix-Marseille University, complemented by a Master's degree and Bachelor's degrees in related fields. Research experience spans several internships focusing on various aspects of rheumatoid arthritis and neutrophil function.
This person is not in any teams
DIAGAST
1 followers
Receiving blood is receiving life. DIAGAST’s goal is to help healthcare professionals transmit life with the help of the best blood group determination technologies. Even though it is not always a matter of life and death, transfusion errors are never acceptable. Over the last 30 years, DIAGAST has developed unparalleled expertise and know-how in the transfusion sector. DIAGAST develops, manufactures and markets reagents (for blood group determination), miniaturized laboratories for manual analysis and automated systems. DIAGAST also ensures the research, manufacturing and marketing of all its products. Moreover, DIAGAST offers a wide range of related services, such as a training center for their automated systems, a hotline and on-site follow-up on automaton calibration. We even make control and measurement tools available over the Internet. DIAGAST is now the worldwide leader in the marketing and development of reagents and instrumentation systems that aim to ensure donor and patient compatibility during blood transfusions.